It’s important to recognize that an R&D organization must use its resources to maximize the return on a company’s investment. To do that, investments must be made in therapeutic areas where the odds of technical, regulatory and commercial success are high. Unfortunately, CVD is not such an area.
The Conundrum Of Investing In Cardiovascular Versus Rare Diseases R&D
